Kurt M. Eichler, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), sold 40,000 shares at $1.26 ($50K) on 2019-12-30, disclosed to the SEC on 2020-01-02.
Tax-driven sale ($50k) by Director — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| Filing → |
| SBPH | BUY | 2016-11-10 | $61K | — | Filing → |
| SBPH | BUY | 2016-09-20 | $25K | — | Filing → |
| SBPH | BUY | 2016-09-15 | $6K | — | Filing → |